StonvexLoading…
StonvexStonvexStonvexCore line items from BRLT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $437.48M | $422.16M | $446.38M | $439.88M |
Operating Income | $-5.38M | $3.35M | $4.48M | $23.33M |
Net Income | $-3.63M | $541.00K | $584.00K | $2.13M |
EPS (Diluted) | $-0.25 | $0.03 | $0.04 | $0.15 |
Total Assets | $200.90M | $281.25M | $273.58M | $262.57M |
Total Liabilities | $121.27M | $171.86M | $176.13M | $169.43M |
Cash & Equivalents | $79.09M | $161.93M | $155.81M | $154.65M |
Free Cash Flow OCF − CapEx | $5.75M | $12.69M | $14.27M | $5.38M |
Shares Outstanding | 14.75M | 98.35M | 97.06M | 96.51M |